Manufacturing and Production

Showing 15 posts of 5863 posts found.

stocks1

Colombian pharma market to break $7 billion by 2020

October 24, 2016 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Colombia, market report

According to new findings from GlobalData, the Colombian pharmaceutical market is due to grow from $5 billion in 2015 to …
lilly_scientists

Eli Lilly gains accelerated approval from FDA for soft tissue sarcoma drug

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, FDA, US, soft tissue sarcoma

Eli Lilly received the positive news that their drug, Lartruvo, has been granted accelerated approval for use in conjunction with …
sunset-flag-america-fields

The Pharmafocus guide to the US presidential election 2016

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing US election, feature

The US presidential election is mere weeks away, and the pharmaceutical industry and drug pricing have occupied quite a large …
novartis_window

Novartis in collaboration deal worth potential $1.2 billion with Cerulean

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cerulean, NDC, Novartis

Novartis has signed an agreement with Cerulean Pharma, worth a potential $1.2 billion depending on milestones met, to co-develop nanoparticle-drug …
celgene_1_02

Celgene’s Otezla approved by NICE for chronic plaque psoriasis

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, NICE, apremilast, otezla

NICE has given its approval to another indication for Celgene’s Otezla (apremilast), meaning NHS patients now have access to the …

MSD’s antiviral drug hits endpoint targets in Phase III trials

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AiCuris, MSD, Merck, bone marrow, letermovir, transplant

MSD, known as Merck in the US, released news of the successful meeting of its primary endpoints in its Phase …
f_44819

Oxford Genetics boosts cell/gene therapy R&D with new facility

October 20, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Oxford Genetics, expansion

Oxford Genetics has moved its operations to the Medawar centre in the city, upscaling its infrastructure and staff to keep …

Recipharm to open largest Nordic GLP bioanalysis lab

October 19, 2016 Manufacturing and Production, Research and Development Recipharm, Sweden, expansion

Contract development and manufacturing firm Recipharm has announced plans to invest five million Swedish Krona (SEK) in a new GLP-compliant …
shutterstock_138095450

Quark to set up “largest biotechnology fund in Canada” for $500m

October 18, 2016 Manufacturing and Production, Research and Development Canada, Quark Venture, Vancouver, fund

Canadian venture capital firm Quark Venture is to partner up with China’s GF Securities to launch a “largest of its …
pillsphotos1

Research suggests that anti-inflammatory drugs may offer alternative to anti-depressants

October 18, 2016 Manufacturing and Production University of Cambridge, anti-cytokine, anti-inflammatory, depression

Researchers at the University of Cambridge analysed data from 20 clinical trials involving anti-cytokine drugs, which are commonly used to …
c_agsandrew_-_fotolia

IBM and Quest forge precision cancer treatment partnership

October 18, 2016 Manufacturing and Production, Medical Communications Cancer, Precision Medicine, Quest, ibm, oncology

IBM has revealed it is to join forces with clinical laboratory service provider Quest Diagnostics in a bid to utilise …
pfizer_sky

Pfizer sets release date for rival to J&J’s blockbuster drug

October 18, 2016 Manufacturing and Production J&J, JJ, Johnson & Johnson, Pfizer, Remicade, inflectra

Pfizer have announced that they will begin shipping their rival to Johnson & Johnson’s Remicade by the end of November. …
ipos0_l

Regeneron and Teva’s experimental drug halted by FDA clinical hold

October 17, 2016 Manufacturing and Production Regeneron, Teva, back pain, osteoarthritis

Regeneron Pharmaceuticals and Teva Pharmaceuticals had only just agreed a deal worth a potential $2.6 billion to co-develop Regeneron’s fasinumab …

Wickham Laboratories Announces Renewal of FDA Accreditation

October 17, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Wickham Laboratories announces that the United States Food and Drug Administration (FDA) inspection conducted 15th-17th of February 2016 has now …
chris_nowers

Kite Pharma appoints Chris Nowers as Head of Europe

October 14, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chris Nowers, London, kite pharma

Kite Pharma announced on 13 October that it had appointed Chris Nowers as its Head of Europe. Nowers will be …
The Gateway to Local Adoption Series

Latest content